Buscar resultados de ensayos clínicos
Familial Lipoprotein Lipase Deficiency - 13 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. Condición: Familial Chylomicronemia Syndrome (FCS) (HLP Type I) Fecha: 2012-04-27 Intervenciones: Drug: LCQ908 |
Completed |
Nombre del estudio: The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condición: Familial Chylomicronemia Syndrome Fecha: 2014-08-05 Intervenciones:
|
Completed |
Nombre del estudio: A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome Condición: Familial Chylomicronemia Syndrome (FCS) Fecha: 2011-12-21 Intervenciones:
|
Completed |
Nombre del estudio: Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X] Condición: Familial Lipoprotein Lipase Deficiency Fecha: 2010-04-22 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects Condición: Familial Lipoprotein Lipase Deficiency Fecha: 2009-04-30 Intervenciones:
|
Terminated |
Nombre del estudio: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies Condición: Hyperlipoproteinemia Type I Fecha: 2011-09-28 |
Recruiting |
Nombre del estudio: Orlistat for the Treatment of Type I Hyperlipoproteinemia Condición:
Fecha: 2016-05-02 Intervenciones: Drug: Orlistat Orlistat is a gastric and pancreatic lipase inhibitor that is approved by the FDA for wei |
Recruiting |
Nombre del estudio: The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condición:
|
Recruiting |
Nombre del estudio: Alipogene Tiparvovec for the Treatment of LPLD Patients Condición: LPL Deficiency Fecha: 2016-05-10 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment Condición: Lipoprotein Lipase Deficiency Fecha: 2016-01-12 Intervenciones: Drug: Heparin Participants will be given IV heparin in order to release lipoprotein lipase from capillar |